Henk Veeze is a pediatrician and was one of the founders of Diabeter in 2006. At Diabeter he is also senior international medical director and general manager. Previous positions include pediatrician at Erasmus MC-Sophia Children’s Hospital, Rotterdam, and pediatrician and vice-president of medical staff at the IJsselland Hospital, Rotterdam, The Netherlands.
Selected important publications include:
Heyden JCV, Birnie E, Bovenberg SA, Dekker P, Veeze HJ1, Mul D, Aanstoot HJ. Losing Track of Lipids in Children and Adolescents with Type 1 Diabetes: Towards Individualized Patient Care. Exp Clin Endocrinol Diabetes. 2019 Jul 4. doi: 10.1055/a-0950-9677. [Epub ahead of print]
Sumnik Z, Szypowska A, Iotova V, Bratina N, Cherubini V, Forsander G, Jali S, Raposo JF, Stipančic G, Vazeou A, Veeze H, Lange K; SWEET study group. Persistent heterogeneity in diabetes technology reimbursement for children with type 1 diabetes: The SWEET perspective. Pediatr Diabetes. 2019 Jun;20(4):434-443.
Witsch M, Kosteria I, Kordonouri O, Alonso G, Archinkova M, Besancon S, Birkebæk NH, Bratina N, Cherubini V, Hanas R, Hasnani D, Iotova V, Raposo JF, Schwandt A, Sumnik Z, Svensson J, Veeze H; SWEET Group. Possibilities and challenges of a large international benchmarking in pediatric diabetology-The SWEET experience. Pediatr Diabetes. 2016 Oct;17 Suppl 23:7-15.
A complete bibliography can be found here.